Pharma Stocks
-
Ionis Pharmaceuticals (IONS) Stock Looks Fully Priced On Sales Yet Mixed On Value
Ionis Pharmaceuticals stock has delivered a 60.7% gain over the past five years, yet current valuation checks using market multiples…
Read More » -
Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli
Johnson & Johnson stock has delivered a 3 year total return of 80.4%, yet the latest valuation checks send mixed…
Read More » -
Symbiotec Pharmalab shares make muted debut, later gain 8%
Symbiotec Pharmalab shares made a muted debut on Tuesday, listing nearly 1% lower on the BSE before recovering to trade…
Read More » -
Symbiotec Pharmalab shares to list today; GMP signals 19% listing gain
Shares of Symbiotec Pharmalab are set to debut on the BSE and NSE on Tuesday, with sentiment in the grey…
Read More » -
Zealand Pharma – Transactions related to share buy-back program (week 35, 2026)
Zealand Pharma Company announcement No. 44 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 35, 2026)…
Read More » -
7 Red Days In A Row: BridgeBio Pharma Stock Is Down 8.8%
A seven-day slide has put this biotech stock’s momentum in the spotlight, raising questions about its underlying business fundamentals. BridgeBio…
Read More » -
Top stocks in news: HDFC Bank, RIL, Augmont, M&M, LEAP, Auro Pharma, Cipla, NBCC, Clean Max, Ola
Corporate actions today: Shares of Glenmark Pharmaceuticals, Ganesh Housing, Ion Exchange India, Mastek, Orbit Exports and Triveni Engineering & Industries…
Read More » -
Jazz Pharmaceuticals (JAZZ) Could Be 13% Undervalued On FDA Approval Of Ziihera
Jazz Pharmaceuticals (JAZZ) is in focus after the FDA approved Ziihera-based regimens for first-line treatment of adults with unresectable locally…
Read More » -
Is Ligand Pharmaceuticals (LGND) Undervalued On Its Conference Appearance?
Conference appearance puts focus on Ligand Pharmaceuticals stock Ligand Pharmaceuticals (LGND) is set to present at the 17th Annual Midwest…
Read More » -
Is Crinetics Pharmaceuticals (CRNX) Fully Priced After A 3.9x Run?
Crinetics Pharmaceuticals stock has delivered very strong multi year gains, yet the current valuation checks do not point to a…
Read More »